• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience.

作者信息

Becatti Matteo, Urban Maria Letizia, Taurisano Giusi, Mannucci Amanda, Barygina Victoria, Pescitelli Leonardo, Prignano Francesca, Silvestri Elena, Taddei Niccolò, Lotti Torello, Fiorillo Claudia, Emmi Giacomo

机构信息

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Nephrology Unit, Parma University Hospital, Parma, Italy.

出版信息

Dermatol Ther. 2018 Sep;31(5):e12675. doi: 10.1111/dth.12675. Epub 2018 Aug 22.

DOI:10.1111/dth.12675
PMID:30133998
Abstract
摘要

相似文献

1
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience.
Dermatol Ther. 2018 Sep;31(5):e12675. doi: 10.1111/dth.12675. Epub 2018 Aug 22.
2
Secukinumab: a review in moderate to severe plaque psoriasis.司库奇尤单抗：治疗中重度斑块状银屑病的研究进展。
Am J Clin Dermatol. 2015 Aug;16(4):323-330. doi: 10.1007/s40257-015-0143-7.
3
Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.司库奇尤单抗治疗中重度斑块状银屑病的临床与经济学综述
Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):153-66. doi: 10.1586/14737167.2016.1133301. Epub 2016 Feb 2.
4
Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.使用白细胞介素-17A抗体司库奇尤单抗治疗急性泛发性脓疱型银屑病。
JAMA Dermatol. 2016 Apr;152(4):482-4. doi: 10.1001/jamadermatol.2015.4686.
5
First case of secukinumab successful therapy in a very elderly psoriatic patient.司库奇尤单抗成功治疗高龄银屑病患者的首例病例。
Dermatol Ther. 2018 Sep;31(5):e12668. doi: 10.1111/dth.12668. Epub 2018 Sep 13.
6
Safety of secukinumab in the treatment of psoriasis.司库奇尤单抗治疗银屑病的安全性。
Expert Opin Drug Saf. 2016 Oct;15(10):1413-20. doi: 10.1080/14740338.2016.1221923. Epub 2016 Aug 22.
7
The impact of long-term secukinumab treatment on Epstein-Barr virus and cytomegalovirus loads in patients with psoriasis.长期司库奇尤单抗治疗对银屑病患者EB病毒和巨细胞病毒载量的影响。
Int J Dermatol. 2016 Nov;55(11):e600-e602. doi: 10.1111/ijd.13346.
8
Effects of risankizumab in patients with psoriasis previously treated with guselkumab: a case series.
Eur J Dermatol. 2021 Apr 1;31(2):251-252. doi: 10.1684/ejd.2021.4001.
9
Secukinumab (AIN-457) for the treatment of Psoriasis.司库奇尤单抗（AIN-457）用于治疗银屑病。
Expert Rev Clin Pharmacol. 2016;9(2):187-202. doi: 10.1586/17512433.2016.1129894.
10
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study.司库奇尤单抗治疗对银屑病患者人乳头瘤病毒感染率的影响：一项初步研究。
J Am Acad Dermatol. 2016 Jul;75(1):224-6. doi: 10.1016/j.jaad.2016.02.1168.

引用本文的文献

1
Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?慢性炎症性皮肤病中炎症驱动的分子衰老：生物疗法有作用吗？
Cells. 2025 Sep 15;14(18):1442. doi: 10.3390/cells14181442.
2
Predictive Performances of Blood-Count-Derived Inflammatory Markers for Liver Fibrosis Severity in Psoriasis Vulgaris.血计数衍生炎症标志物对寻常型银屑病患者肝纤维化严重程度的预测性能。
Int J Mol Sci. 2023 Nov 29;24(23):16898. doi: 10.3390/ijms242316898.
3
Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches.
银屑病的自身免疫与氧化应激：不同治疗方法诱导的变化。
Oxid Med Cell Longev. 2022 Mar 12;2022:2249834. doi: 10.1155/2022/2249834. eCollection 2022.
4
Serum C-reactive protein to albumin ratio as a novel inflammation biomarker in psoriasis patients treated with adalimumab, ustekinumab, infliximab, and secukinumab: a retrospective study.血清C反应蛋白与白蛋白比值作为接受阿达木单抗、乌司奴单抗、英夫利昔单抗和司库奇尤单抗治疗的银屑病患者的新型炎症生物标志物：一项回顾性研究。
Croat Med J. 2020 Aug 31;61(4):333-337. doi: 10.3325/cmj.2020.61.333.